Galecto Stock Working Capital
| GLTO Stock | USD 4.23 0.06 1.40% |
Galecto fundamentals help investors to digest information that contributes to Galecto's financial success or failures. It also enables traders to predict the movement of Galecto Stock. The fundamental analysis module provides a way to measure Galecto's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Galecto stock.
Galecto |
Galecto Company Working Capital Analysis
Galecto's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Galecto Working Capital | 30.94 M |
Most of Galecto's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galecto is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
According to the company's disclosures, Galecto has a Working Capital of 30.94 M. This is 92.73% lower than that of the Biotechnology sector and 94.25% lower than that of the Health Care industry. The working capital for all United States stocks is 97.91% higher than that of the company.
Galecto Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galecto's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galecto could also be used in its relative valuation, which is a method of valuing Galecto by comparing valuation metrics of similar companies.Galecto is currently under evaluation in working capital category among its peers.
Galecto Fundamentals
| Return On Equity | -0.73 | ||||
| Return On Asset | -0.34 | ||||
| Current Valuation | (14.08 M) | ||||
| Shares Outstanding | 1.32 M | ||||
| Shares Owned By Insiders | 3.45 % | ||||
| Shares Owned By Institutions | 13.00 % | ||||
| Number Of Shares Shorted | 20.41 K | ||||
| Price To Book | 0.27 X | ||||
| EBITDA | (22.26 M) | ||||
| Net Income | (21.44 M) | ||||
| Cash And Equivalents | 79.03 M | ||||
| Cash Per Share | 3.11 X | ||||
| Total Debt | 61 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 10.98 X | ||||
| Book Value Per Share | 16.70 X | ||||
| Cash Flow From Operations | (18.62 M) | ||||
| Short Ratio | 1.00 X | ||||
| Earnings Per Share | (19.11) X | ||||
| Price To Earnings To Growth | (0.01) X | ||||
| Target Price | 8.0 | ||||
| Number Of Employees | 13 | ||||
| Beta | 1.19 | ||||
| Market Capitalization | 5.57 M | ||||
| Total Asset | 17.13 M | ||||
| Retained Earnings | (277.52 M) | ||||
| Working Capital | 30.94 M | ||||
| Net Asset | 17.13 M |
About Galecto Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galecto's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galecto using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galecto based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Galecto
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Galecto position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Galecto will appreciate offsetting losses from the drop in the long position's value.Moving together with Galecto Stock
Moving against Galecto Stock
| 0.7 | CPIX | Cumberland Pharmaceuticals | PairCorr |
| 0.64 | FNA | Paragon 28 | PairCorr |
| 0.62 | CMRX | Chimerix Sell-off Trend | PairCorr |
The ability to find closely correlated positions to Galecto could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Galecto when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Galecto - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Galecto to buy it.
The correlation of Galecto is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Galecto moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Galecto moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Galecto can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Galecto Piotroski F Score and Galecto Altman Z Score analysis. To learn how to invest in Galecto Stock, please use our How to Invest in Galecto guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Galecto. If investors know Galecto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Galecto listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Galecto is measured differently than its book value, which is the value of Galecto that is recorded on the company's balance sheet. Investors also form their own opinion of Galecto's value that differs from its market value or its book value, called intrinsic value, which is Galecto's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Galecto's market value can be influenced by many factors that don't directly affect Galecto's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Galecto's value and its price as these two are different measures arrived at by different means. Investors typically determine if Galecto is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Galecto's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.